Balance Sheet
Cash Flow Statement
Amortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Albemarle (ALB-PA) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Albemarle (ALB-PA) over the last 17 years, with Q4 2025 value amounting to -$533.0 million.

  • Albemarle's Cash from Financing Activities fell 47386.98% to -$533.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$834.2 million, marking a year-over-year decrease of 16717.91%. This contributed to the annual value of -$834.2 million for FY2025, which is 16717.91% down from last year.
  • As of Q4 2025, Albemarle's Cash from Financing Activities stood at -$533.0 million, which was down 47386.98% from -$90.5 million recorded in Q3 2025.
  • Albemarle's 5-year Cash from Financing Activities high stood at $1.6 billion for Q1 2024, and its period low was -$533.0 million during Q4 2025.
  • For the 5-year period, Albemarle's Cash from Financing Activities averaged around $84.7 million, with its median value being -$77.9 million (2022).
  • As far as peak fluctuations go, Albemarle's Cash from Financing Activities surged by 189177.15% in 2022, and later tumbled by 47386.98% in 2025.
  • Quarter analysis of 5 years shows Albemarle's Cash from Financing Activities stood at $308.6 million in 2021, then plummeted by 196.99% to -$299.4 million in 2022, then surged by 232.62% to $397.0 million in 2023, then tumbled by 123.4% to -$92.9 million in 2024, then tumbled by 473.87% to -$533.0 million in 2025.
  • Its Cash from Financing Activities stands at -$533.0 million for Q4 2025, versus -$90.5 million for Q3 2025 and -$90.6 million for Q2 2025.